Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme

Biotechnology and Biotechnological Equipment

Volumn 28, Issue 2, 2014, Pages 322-326

  Sheng, Shujing ^a,b   Wang, Yonggang ^a   Long, Chaofeng ^b   Su, Weiwei ^a   Rong, Xia ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Zhongsheng Pharmaceutical Co Ltd   (China)

^c Guangzhou Blood Center   (China)

Author keywords

Angiotensin converting enzyme; Fufang Xueshuantong capsule; Panax notoginseng; Saponins

Indexed keywords

CARDIOVASCULAR SYSTEM; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; PLANT EXTRACTS;

ANGIOTENSIN-CONVERTING ENZYME; BIOCHEMICAL TESTS; CARDIO-VASCULAR DISEASE; FUFANG XUESHUANTONG CAPSULE; PANAX NOTOGINSENG; PHARMACOLOGICAL EFFECTS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SAPONINS;

ENZYME ACTIVITY;

EID: 84905908944     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2014.911611     Document Type: Article

References (22)

1. Chrysant SG, Chrysant GS, Chrysant C, Shiraz M. The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade. Curr Clin Pharmacol. 2010;5:89-95.
2. Lapointe N, Rouleau JL. Activation of vascular tissue angiotensin-converting enzyme (ACE) in heart failure. Effects of ACE inhibitors. J Am Coll Cardiol. 2002;39:776-779.
3. Rodriguez PL. The role of angiotensin-converting enzyme inhibitors (ACEI) in patients with cardiovascular risk. Revista Clinica Espanola. 2004;204:592-593.
4. Miller DG, Sweis RT, Toerne TS. Penile angioedema developing after 3 years of ACEI therapy. J Emerg Med. 2012;43:273-275.
5. Serra CP, Cortes SF, Lombardi JA, Braga DOA, Braga FC. Validation of a colorimetric assay for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE) from plant extracts. Phytomedicine. 2005;12:424-432.
6. Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Discov Med. 2005;5:455-461.
7. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ, Chen Z. Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA. 2008;105:4826-4831.
8. Li GH, Liu H, Shi YH, Le GW. Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides. J Pharm Biomed Anal. 2005;37:219-224.
9. Murray BA, Walsh DJ, FitzGerald RJ. Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. J Biochem Biophys Methods. 2004;59:127-137.
10. Ojeda D, Jimenez-Ferrer E, Zamilpa A, Herrera-Arellano A, Tortoriello J, Alvarez L. Inhibition of angiotensin converting enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol. 2010;127:7-10.
11. Sakaida H, Nagao K, Higa K, Shirouchi B, Inoue N, Hidaka F, Kai T, Yanagita T. Effect of Vaccinium ashei reade leaves on angiotensin converting enzyme activity in vitro and on systolic blood pressure of spontaneously hypertensive rats in vivo. Biosci Biotechnol Biochem. 2007;71:2335-2337.
12. Loizzo MR, Tundis R, Conforti F, Statti GA, Menichini F. Inhibition of angiotensin converting enzyme activity by five Senecio species. Pharm Biol. 2009;6:516-520.
13. Ichikawa H, Wang X, Konishi T. Role of component herbs in antioxidant activity of Shengmai San a traditional Chinese medicine formula preventing cerebral oxidative damage in rat. Am J Chin Med. 2003;31:509-521.
14. Dong TT, Cui XM, Song ZH, Zhao KJ, Ji ZN, Lo CK, Tsim KW. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem. 2003;51:4617-4623.
15. Wan JB, Yang FQ, Li SP, Wang YT, Cui XM. Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. J Pharm Biomed Anal. 2006;41:1596-1601.
16. Lau AJ, Woo SO, Koh HL. Analysis of saponins in raw and steamed Panax notoginseng using high-performance liquid chromatography with diode array detection. J Chromatogr A. 2003;1011:77-87.
17. Liu B, Yang J, Ma Y, Yuan E, Chen C. Antioxidant and angiotensin converting enzyme (ACE) inhibitory activities of ethanol extract and pure flavonoids from Adinandra nitida leaves. Pharm Biol. 2010;48:1432-1438.
18. Loizzo MR, Said A, Tundis R, Rashed K, Statti GA, Hufner A, Menichini F. Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytotherapy Res. 2007;21:32-36.
19. Csermely P, Agoston V, Pongor S. The efficiency of multitarget drugs: the network approach might help drug design. Trends Pharmacol Sci. 2005;26:178-182.
20. Hoo RL, Wong JY, Qiao C, Xu A, Xu H, Lam KS. The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity. Nutr Metabolism. 2010;7:67-78.
21. Joo IW, Ryu JH, Oh HJ. The influence of Sam-Chil-Geun (Panax notoginseng) on the serum lipid levels and inflammations of rats with hyperlipidemia induced by poloxamer-407. Yonsei Med J. 2010;51:504-510.
22. Shang Q, Xu H, Huang L. Tanshinone IIA: a promising natural cardioprotective agent. Evid Based Complement Altern Med. 2012;2012. 716459-716466.